RetinalGenix Technologies Inc. (RTGN)

OTCMKTS · Delayed Price · Currency is USD
3.200
-0.350 (-9.86%)
At close: Nov 5, 2025
-8.57%
Market Cap 59.54M
Revenue (ttm) n/a
Net Income (ttm) -2.67M
Shares Out 18.60M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 1,703
Open 3.200
Previous Close 3.550
Day's Range 3.200 - 3.200
52-Week Range 0.250 - 6.360
Beta -3.92
RSI 47.87
Earnings Date Mar 31, 2026

About RetinalGenix Technologies

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-20... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2017
Country United States
Stock Exchange OTCMKTS
Ticker Symbol RTGN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.